#DFTX
Siren, L.L.C – Q3 2026 13F Update

• Total Portfolio Value: $4.2B (111 stocks)
• New Position: $ADRX ($38M)
• Biggest Add: $TYRA (+368% shares)
• Sold Out: $DFTX
• Largest Holding: $SRRK (11% of portfolio)

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#13F #Investing
Siren, L.L.C: Q3 2026 13F portfolio changes
18 new positions, 24 sold out, 17 added to, 35 trimmed.
elixstocks.com
November 12, 2026 at 5:54 PM
$DFTX Definium Therapeutics: cash ~$1.05B, runway into 2030 (Q3 2026)
Hub: https://www.merlintrader.com/definium-therapeutics-stock-hub/?utm_source=bluesky&utm_medium=social&utm_campaign=flyer-q3-2026&utm_content=dftx

Not investment advice.
November 10, 2026 at 8:50 PM
Definium (#$DFTX) Technical Levels: Options Flow Mixed Between $34.65 and $36.49.

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Read the full article for the full details.
#optionsflow #stocks #optionstrading #trading
Definium (DFTX) Technical Levels: Options Flow Mixed Between $34.65 and $36.49
DFTX at $35.39: support $34.65, resistance $36.49; the chart, options flow and dark pools are mixed.
globaltradersacademy.com
November 10, 2026 at 7:17 AM
Definium Therapeutics $DFTX reported Q3 2026 EPS of -$0.46, beating the -$0.56 estimate by 17.9%. Revenue was $0. No analyst estimate was published for revenue.

https://fundspec.ai/s/DFTX/earnings
50+ fundamentals like ROIC and free cash flow yield, ranked against the whole market.
November 9, 2026 at 9:17 PM
🚨 $DFTX
On November 9, 2026, Definium Therapeutics, Inc. issued a press release announcing its financial results for its fiscal quarter ended September 30, 2026, as well as information regarding a conference call to discuss these financial results and the Company’s recent corporate highlights.
SEC Filing: DFTX
Click to view the official SEC document.
www.sec.gov
November 9, 2026 at 9:23 PM
November 9, 2026 at 12:35 PM
$TTEC-1 $LIFE-1 $GABC-1 $IPX-1 $AFRM-1 $VET-1 $UPRO-1 $GOOG-1 $HAYW-1 $APO-1 $MCHP-1 $MSFU-1 $OBDC-1 $XLE-1 $RIVN-1 $FITB-1 $CROX-1 $VIAV-1 $DRAM-1 $MAR-1 $SSNC-1 $CNH-1 $XLI-1 $LOPE-1 $ENGS-1 $BAC-1 $CTMX-1 $VIST-1 $AAPL-1 $GFL-1 $UVXY-1 $PHVS-1 $UDOW-1 $DFTX-1 $ADPT-1
November 10, 2026 at 9:21 PM
#$DFTX
Definium Therapeutics, Inc. will share positive topline Phase 3 Panorama results for DT120 in generalized anxiety disorder at a medical congress for the first time at the NEI Fall Congress, November 5 to 8.
prismmarketview.com/companies/de...
Definium Therapeutics
Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-
prismmarketview.com
November 5, 2026 at 1:34 PM
Definium #$DFTX will present at a string of investor conferences.

Shares closed at $32.47 Mon: below SMA50, above SMA200, RSI 37.

Hub: www.merlintrader.com/definium-the...

Not investment advice.
DFTX Stock: Definium News, DT120 & FDA Filing Path
Definium Therapeutics stock news and analysis: DT120 pivotal evidence, the conditional FDA filing path, liquidity and the key psychiatric drug risks for DFTX.
www.merlintrader.com
November 3, 2026 at 4:19 PM
$DFTX breakout moving down 11.4% to $32.20 from $36.33 on 1,331,566 shares. Verticals can fade fast on the open. Tapeboard scann…

Live chart on Tapeboar… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bluesky&utm_content=dftx-down&utm_term=chart-native&s=DFTX
November 2, 2026 at 6:53 PM
Psychedelic Alpha reports Usona has likely filed an NDA for psilocybin in major depression, intensifying competition with #$CMPS and other developers. #$DFTX, #$HELP, #$GHRS notreload.xyz/xy/usona-psi...
Usona Psilocybin NDA Filing Intensifies Competition
Usona’s potential FDA filing for psilocybin makes the competitive landscape more real for Compass, Definium, Helus Pharma and GH Research, analyst says.
notreload.xyz
November 2, 2026 at 8:37 PM
#$DFTX weekly close $36.33 (+1.9% w/w), below SMA50 $37.77 / above SMA200 $29.60, RSI 49.4. Support $32.01, resistance $39.14. Broad market sell-off Friday.

New hub updated: www.merlintrader.com/definium-the...
October 31, 2026 at 9:04 PM
#$DFTX weekly close $36.33 (+1.9% w/w), below SMA50 $37.77 / above SMA200 $29.60, RSI 49.4. Support $32.01, resistance $39.14. Broad market sell-off Friday.

New hub updated: www.merlintrader.com/definium-the...
October 31, 2026 at 9:04 PM
JPMorgan, Raymond James and Canaccord started coverage on #$CCCC, #$DFTX, #$PALI and #$LBRX. notreload.xyz/xy/pali-lbrx...
PALI, LBRX, CCCC, DFTX: New Buy Ratings and Upside
Targets imply 88% to 314% upside, with cash into 2027-2030.
notreload.xyz
October 9, 2026 at 12:35 PM
Definium Therapeutics Price Targets Raised After Positive Phase 3 Trial

Definium Therapeutics (DFTX) saw its price targets increased by multiple analysts following the successfu…

Read more: https://embers.news/article/definium-therapeutics-price-targets-raised-after-positive-phase-3-trial-127901
Definium Therapeutics Price Targets Raised After Positive Phase 3 Trial
Definium Therapeutics (DFTX) saw its price targets increased by multiple analysts following the successful completion of its third Phase 3 clinical trial for DT120, an investigational treatment for anxiety. The positive study results have increased confidence in the company's regulatory path as it m
embers.news
October 7, 2026 at 10:36 PM
Latest company news, September 28: Definium announced new employee option grants. Latest clinical result: positive Panorama Phase 3, September 14.
Definium Therapeutics (#$DFTX) Stock Hub: Panorama Positive, Next Comes the FDA Filing Path
www.merlintrader.com/definium-the...
Definium ($DFTX): Panorama Positive, FDA Filing Path
Definium ($DFTX): Panorama met primary and key secondary endpoints in GAD. Q4 2026 pre-NDA meeting, H1 2027 filing plan, safety and regulatory risks.
www.merlintrader.com
October 6, 2026 at 10:07 PM
September 30, 2026 at 8:00 PM
🔴 #DFTX — Roberts Brandi, Chief Financial Officer
SOLD: 3,377 shares @ $36.57
Total: $123K
Filed Sep 24, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/DFTX

#InsiderTrading #DFTX #StockMarket
FormDelta — Insider Trading Alerts
Roberts Brandi just sold $123K in DFTX. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
September 30, 2026 at 1:23 AM